can be used to define the probability of the presence of coronary artery disease and their ability to do so can be confirmed through correlation with results of coronary arteriography. There is at present no widely available gold standard to enable confirmation of the ability of these tests to define the probability of myocardial ischemia per se.
Determination of the effectiveness of a test is dependent on three elements: (1) test sensitivity, (2) test specificity, and (3) prevalence of the disease being tested for. 2 If the prevalence of a disease in the population at hand is known, two other determinations can be made: the positive and negative predictive values of the test, as defined by Bayes' theorem. Bayesian principles apply to any test for which sensitivity, specificity, and prevalence are known. Since the sensitivity and specificity of the noninvasive tests for ischemia, as opposed to coronary artery disease, are not known, nor is its prevalence throughout the wide spectrum of coronary artery disease, the issues involved in assessing the likelihood of silent ischemia from noninvasive testing can be discussed only in a conceptual format. For the purpose of this discussion, we will assume a linear relationship between the presence of coronary disease and myocardial ischemia. The almost certain inexactness of this assumption will not obscure our main aim, which is to illustrate how application of conventional Bayesian concepts can guide the appropriate use of tests for the evaluation of silent myocardial ischemia.
Exercise electrocardiography. The reported sensitivities and specificities of exercise electrocardiography are in the range of 60% to 85%, respectively. Figure 1 CIRCULATION the patient with coronary vasospasm, abnormal coronary vasodilator reserve, and "syndrome X." Thus, a variety of technical and nonischemic conditions influencing the exercise electrocardiogram make it inappropriate to label patients without angina as having silent myocardial ischemia on the basis of a positive exercise electrocardiogram alone. In contrast, situations in which the prevalence of disease is high, the positive exercise electrocardiogram is much more likely to be indicative of coronary disease and, accordingly, may have greater predictive value for ischemia, even in the absence of pain on the exercise test. Ambulatory electrocardiography. The ambulatory electrocardiogram is unlikely to be more specific for coronary artery disease than the exercise electrocardiogram; it may prove to be less specific. Ambulatory electrocardiographic monitoring systems were initially developed for the evaluation of arrhythmias. Due to the low frequency of ST segment signal compared with that of the QRS complex, the requirements for accurate ST segment analysis are very different from those for accurate detection of arrhythmia. The requirements include adequate high-and low-frequency cutoffs, ideally conforming to American Heart Association standards of 0.05 to 100 Hz, a flat amplitude versus frequency response within the pass band, minimal phase shift, and absence of baseline artifact.3 Recently, a variety of manufacturers have claimed to meet the American Heart Association specifications. However, it is important to realize that the specifications are frequently reported simply for the amplifier itself, whereas information is needed on the entire system, including the recorder, the playback system, and the printout of such devices. in normal individuals may result from sudden strenuous exercise not conforming to the kind of controlled exercise seen with graded treadmill exercise. 5 With an expectation that ambulatory monitoring will have a lower specificity than electrocardiographic stress testing for coronary artery disease, the lower specificity dictates, by Bayesian analysis, that for a low prevalence of disease, the likelihood that a positive test is a false-positive one will be even greater than that associated with a positive stress electrocardiogram. Stated more directly, in the asymptomatic patient with a positive ST response on ambulatory monitoring, the likelihood that this response is associated with coronary artery disease (and ischemia) will be even less than the 17% value calculated for the stress electrocardiogram.
A further caveat may be that the criteria for a positive ST segment response during exercise may not be transferable to the ambulatory electrocardiogram. There are no data with which to confirm that the criteria for significant ST segment depression on the ambulatory electrocardiogram (planar or downsloping ST segment depression of 1 mm or greater, measured at 0.08 sec) derived from exercise testing are translatable to the ambulatory state in which the conditions affecting repolarization may be quite different. Independent assessments of validity of the criteria are just beginning to become available through correlation with nonelectrocardiographic indicators of ischemia, such as transiently diminished perfusion during myocardial scintigraphy6 or transient diminutions in left ventricular ejection fraction during ambulatory monitoring.7 These combined studies may eventually provide data on the sensitivity and specificity of ambulatory monitoring for silent ischemia and permit an assessment of the prevalence of silent ischemia throughout the spectrum of coronary artery disease, which is the information necessary to allow the predictive value of a positive or negative test to be known. were found to manifest ischemia by epicardial electrode monitoring at the time of balloon occlusion, but only 6 (43%) manifested ST segment depression on appropriately placed surface leads. 9 Thallium scintigraphy. The sensitivity of thallium testing for coronary artery disease is in the range of 80% to 90% and specificity is high, at approximately 90%, when both fixed and reversible defects are considered abnormal. Even with the high specificity of 90%, however, with a pretest likelihood of coronary disease at 5% (a low-prevalence population), a positive 201T1 test result is likely to be false-positive, with only 27% of patients having disease ( figure 1, right) . Thus, asymptomatic patients should not be labeled as having silent myocardial ischemia on the basis of a positive 2Tl scan alone.
Sources of false-positive thallium defects are most commonly technical, such as shifting breast artifact, inaccurate patient positioning between stress and redistribution studies, diaphragmatic attenuation of the inferior wall, and computer processing errors such as those resulting from over substraction of portions of the myocardium.
Beyond these technical causes, false-positive findings may result from infiltrative or neoplastic myocardial disease, cardiomyopathy, mitral valve prolapse, and some noncoronary but potentially ischemic processes such as aortic stenosis and ischemia with normal coronary arteriograms or syndrome X. The causes of false-positive results, however, are not nearly as numerous or frequent for thallium studies as for exercise electrocardiography, so that this modality offers improved specificity for detecting myocardial ischemia.
In the patient with a high pretest likelihood of disease, 20`T1 testing can be helpful in defining the presence of silent myocardial ischemia. We have recently demonstrated that patients with triple-vessel or left main coronary artery disease without angina often have extensive, reversible thallium defects on treadmill testing. 1 The caveat in this case is the question of the relationship between decreased perfusion and the production of ischemia. Can all detectable perfusion deficits be equated with ischemia? Or, does perfusion need to be reduced to a certain level before ischemia can be said to exist? Exercise radionuclide ventriculography. With the criteria for abnormality on an exercise radionuclide ventriculographic study being an exercise-induced wall motion abnormality and/or an abnormal ejection fraction response, in relatively broad populations the sensitivity of the test approximates 90% (probably higher than that for thallium scintigraphy), and the specificity approximates 80% (lower than that for thallium scintigraphy) for the detection of coronary artery disease. The 
